Reading time: 5 minutes Bekah Schulz The Food and Drug Administration (FDA) is often criticized by patient advocacy groups for taking too much time to approve life-saving drugs. However, the FDA is a difficult situation; if they approve a drug too quickly and it turns out to be unsafe/ineffective, then people are upset. If they... Continue Reading →
Reading time: 3 minutes Bekah Schulz It is well known that biological sex is an important factor in certain types of cancer. Obvious cancers that fall into this category are breast, prostate, uterine, and cervical cancer. These depend on sex-specific organs, as well as hormone levels, that vary between men and women. A previous Oncobites... Continue Reading →
Reading time: 3 minutes Bekah Schulz Natural products, or compounds isolated from plants/microorganisms, have been used as herbal medicines throughout human history. These compounds have many measurable effects. In fact, ⅓ of the top selling pharmaceuticals are natural products or their derivatives. Many antibiotics were discovered from screening these compounds and recently have shown efficacy... Continue Reading →
Reading time: 3 minutes Bekah Schulz It is well accepted that exercise is beneficial for human health and boosts overall energy level. However, the questions remains: can exercise be used as a cancer therapy? Research is indicating that it can. Over the past 20 years, studies have demonstrated that exercise decreases the risk of recurrence... Continue Reading →
Reading time: 4 minutes Bekah Schulz Many people are excited about checkpoint inhibitors in cancer immunotherapy. In fact, the 2018 Nobel Prize in medicine was awarded for the development of two checkpoint inhibitors PD-1/L1 (Opdivo/Keytruda) and CTLA-4 (Yervoy). However, cancer immunotherapy is not a new concept. In fact, in 1986, recombinant interferon (IFN) alpha was... Continue Reading →
OncoBites 